United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin®
Go back to United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin®| Medtronic Inc. (NYSE: MDT) | Delayed: 92.13 -0.64 (0.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $89.27 | |||
| Open | $92.28 | 52 Week Low | $71.03 | |||
| Day High | $93.03 | P/E | 26.17 | |||
| Day Low | $92.04 | EPS | $3.52 | |||
| Volume | 15,446,226 | |||||
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 494.63 -2.64 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $497.27 | 52 Week High | $164.04 | |||
| Open | $498.07 | 52 Week Low | $97.52 | |||
| Day High | $499.23 | P/E | 90.43 | |||
| Day Low | $492.57 | EPS | $5.47 | |||
| Volume | 1,501,109 | |||||
